Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Worrying About Frankenstein’s Monster
A specter is haunting Europe—called the “precautionary principle”. As generally defined, the precautionary principle states that a product or technology can be banned even if…
Citation
Cancer Doctors on the FDA
Op-Eds
Battling Hunger With Biotechnology
Needless restrictions on agricultural biotechnology would harm the world's ability to battle hunger in the 21st century, say Gregory Conko and C.S. Prakash, co-founders…
News Release
FDA Too Slow to Approve New Medical Drugs and Devices
A new nationwide poll of cancer specialists sponsored by the Competitive Enterprise Institute finds many of them believe the FDA is too slow in approving…
Washington Post
US Backs Pediatric Tests In Reversal on Drug Safety
Op-Eds
FDA Overreaches
Who could possibly oppose a pediatric-testing rule for drugs? For starters, physicians and parents who realize that while this rule is supposed to protect children,…